Plant Compound Brachycerine Blocked UV Nerve Damage in Human Skin Samples

A single UV dose destroyed roughly half the nerve endings in unprotected human skin. In the same study, brachycerine — a monoterpene indole alkaloid from the Brazilian tree Psychotria brachyceras — added to an ordinary SPF 15 base, blocked that nerve fiber loss entirely and prevented measurable UV-B DNA damage. The SPF 15 base alone did neither.

The findings landed in Photochemistry and Photobiology (2026, pp. 1–13; DOI: 10.1111/php.70171), from a team led by corresponding author Arthur Germano Fett-Neto at the Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

How was the study built?

No mice. No synthetic skin. The researchers worked ex vivo on real human skin from eight plastic surgery patients — all Caucasian women, ages 14 to 56, undergoing breast or abdominal procedures. That design detail matters: the readouts reflect actual human tissue, not an animal stand-in.

Test formulas contained either brachycerine itself or a whole-leaf extract, both mixed into an SPF 15 base that already carried conventional filters — avobenzone and octyl methoxycinnamate. A placebo arm got the SPF 15 base alone. Samples then took a single 30-minute dose of UV-A or UV-B.

Two endpoints drove the results. Immunofluorescence quantified nerve ending density after exposure. A comet assay on UV-B-irradiated skin measured DNA breakage — the longer the streak, the more damage. Both pointed the same way. Untreated skin and SPF 15-only skin showed expected nerve loss and DNA damage; the brachycerine formulas kept nerve fibers near unexposed levels and shut down detectable DNA damage. Protection tracked dose, with the strongest effect at higher concentrations of compound and extract.

What does this change for formulators?

Right now, not much on the bench. But the mechanistic profile is unusual. Brachycerine absorbs light in the UV range and works as a strong antioxidant — a dual action most current filters can't claim. Conventional ingredients block or absorb UV physically; few also mop up the oxidative damage that slips through. A plant-derived molecule doing both, in human tissue, is a credible lead for next-generation broad-spectrum products.

The safety signal is early but clean. Cytotoxicity testing found brachycerine non-toxic to the mammalian cell line examined.

Why does the tree make it?

Not for us. Psychotria brachyceras produces brachycerine to defend its photosynthesis machinery from solar stress — the same radiation humans worry about, solved by the plant millions of years before sunscreen existed.

Where the evidence stops

This is a laboratory study, not a trial. Key limits to keep in view:

• Eight donors, all Caucasian women aged 14–56; no data on men or other skin tones
• A single 30-minute UV dose, not cumulative real-world exposure
• Safety testing on one cultured cell line, not a finished formula
• The authors note long-term photoprotection in living people is hard to measure and that current guidelines still rely heavily on animal models

Brachycerine is not an approved or available sunscreen ingredient. Nothing here changes what's on shelves today.

Funding came from Brazil's National Council for Scientific and Technological Development (CNPq, grant 310775/2021-3) and CAPES (finance code 001), which also covered the publication charge. The paper carries no separate conflict-of-interest statement; data are available from the corresponding author on reasonable request.

Whether brachycerine ever earns a place in a tube depends on clinical testing in living skin, across skin types, under real sunlight — but as a dual-action, plant-derived photoprotective candidate, it has cleared the first ex vivo hurdle.